Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
XOMA Royalty Enters into Agreement to Acquire Generation Bio
-
Generation Bio delivers siRNA to T cells in primate study
-
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
-
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference
-
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
-
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
-
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
-
TD Cowen Downgrades Generation Bio (GBIO) to Market Perform, 'moving to the sidelines until we have better clarity'
-
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
-
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
-
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
-
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
-
Generation Bio Announces Closing of Public Offering
-
Generation Bio Announces Closing of Public Offering
-
Generation Bio Co. (GBIO) Prices 8M Share Common Offering at $24.50/Sh
-
Generation Bio Announces Pricing of Public Offering
-
Generation Bio Announces Pricing of Public Offering
-
UPDATE: Cowen Starts Generation Bio (GBIO) at Outperform
-
Generation Bio Announces Closing of Initial Public Offering
-
Generation Bio Announces Closing of Initial Public Offering
-
Generation Bio (GBIO) IPO Opens 17% Higher
-
Generation Bio Co. (GBIO) Prices 10.526M Share IPO at $19/Sh
-
Generation Bio Announces Pricing of Initial Public Offering
-
Generation Bio Announces Pricing of Initial Public Offering

